These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19597351)

  • 1. Exploring Rak tyrosine kinase function in breast cancer.
    Yim EK; Siwko S; Lin SY
    Cell Cycle; 2009 Aug; 8(15):2360-4. PubMed ID: 19597351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
    Yim EK; Peng G; Dai H; Hu R; Li K; Lu Y; Mills GB; Meric-Bernstam F; Hennessy BT; Craven RJ; Lin SY
    Cancer Cell; 2009 Apr; 15(4):304-14. PubMed ID: 19345329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb.
    Craven RJ; Cance WG; Liu ET
    Cancer Res; 1995 Sep; 55(18):3969-72. PubMed ID: 7664264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor.
    Jin L; Craven RJ
    Oncogene; 2014 Jan; 33(3):326-35. PubMed ID: 23318459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase.
    Meyer T; Xu L; Chang J; Liu ET; Craven RJ; Cance WG
    Int J Cancer; 2003 Mar; 104(2):139-46. PubMed ID: 12569567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.
    Brauer PM; Tyner AL
    Cell Cycle; 2009 Sep; 8(17):2728-32. PubMed ID: 19652529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.
    Cance WG; Craven RJ; Bergman M; Xu L; Alitalo K; Liu ET
    Cell Growth Differ; 1994 Dec; 5(12):1347-55. PubMed ID: 7696183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
    Goel RK; Lukong KE
    Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation.
    Annerén C; Lindholm CK; Kriz V; Welsh M
    Curr Mol Med; 2003 Jun; 3(4):313-24. PubMed ID: 12776987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.
    Imawari Y; Mimoto R; Hirooka S; Morikawa T; Takeyama H; Yoshida K
    Cancer Sci; 2018 Feb; 109(2):363-372. PubMed ID: 29193658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
    Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
    Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
    Kyriacou KC; Iacovou F; Adamou A; Hadjisavvas A; Rakowicz-Szulczynska EM
    Exp Mol Pathol; 2000 Aug; 69(1):27-36. PubMed ID: 10891290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak.
    Chandrasekharan S; Qiu TH; Alkharouf N; Brantley K; Mitchell JB; Liu ET
    Mol Cell Biol; 2002 Jul; 22(14):5235-47. PubMed ID: 12077350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity.
    Welsh M; Welsh C; Ekman M; Dixelius J; Hägerkvist R; Annerén C; Akerblom B; Mahboobi S; Chandrasekharan S; Liu ET
    Biochem J; 2004 Aug; 382(Pt 1):261-8. PubMed ID: 15186217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
    Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
    J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
    Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
    Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinases in human breast cancer.
    Cance WG; Liu ET
    Breast Cancer Res Treat; 1995 Jul; 35(1):105-14. PubMed ID: 7612897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of the viral RAK alpha gene in diagnosis of malignant versus nonmalignant tumors of the ovary and uterus.
    Rakowicz-Szulczynska EM
    Clin Diagn Lab Immunol; 2000 May; 7(3):360-5. PubMed ID: 10799446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
    Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
    Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of the cell cycle by breast tumor kinase (Brk).
    Chan E; Nimnual AS
    Int J Cancer; 2010 Dec; 127(11):2723-31. PubMed ID: 20162673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.